These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 375209)

  • 1. [Pharmacological inhibition of platelet aggregation in primary and secondary prevention of ischemic heart disease].
    Gryglik J
    Pol Tyg Lek; 1979 Mar; 34(13):509-11. PubMed ID: 375209
    [No Abstract]   [Full Text] [Related]  

  • 2. Status of antiplatelet drugs in coronary heart disease.
    Mehta J; Mehta P
    JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Secondary prevention of coronary disease with platelet aggregation inhibiting drugs. Preliminary report].
    Caruzzo C; Belli R; Biasci R; Gaschino G; Bruna C
    Minerva Cardioangiol; 1979 Jun; 27(6):367-72. PubMed ID: 38413
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anti-aggregation therapy of patients with ischemic heart disease].
    Liusov VA; Savenkov MP
    Ter Arkh; 1988; 60(8):55-9. PubMed ID: 3227479
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antiaggregants of thrombocytes in ischemic heart disease].
    Beloev I ; Tomov I; TŭrnovskaR
    Vutr Boles; 1985; 24(5):1-6. PubMed ID: 2868572
    [No Abstract]   [Full Text] [Related]  

  • 6. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experimental basis of platelet aggregation inhibition by acetylsalicylic acid.
    Born GV; Görög P; Begent NA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):719-24. PubMed ID: 6083947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prophylactic value of platelet anti-aggregants in coronary disease].
    Verstraete M
    Clin Ter; 1979 Oct; 91(2):117-27. PubMed ID: 396098
    [No Abstract]   [Full Text] [Related]  

  • 9. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F; Praticò D; Iuliano L; Balsano F
    J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiplatelet drugs (author's transl)].
    Dechavanne M; Follea G; Trzeciak MC
    Anesth Analg (Paris); 1979; 36(7-8):283-7. PubMed ID: 525834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low doses of aspirin and dipyridamole on platelet aggregation in the dog coronary artery.
    Weselcouch EO; Humphrey WR; Aiken JW
    J Pharmacol Exp Ther; 1987 Jan; 240(1):37-43. PubMed ID: 3543298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Indications and uncertainties of antiaggregating agents].
    Verstraete M
    Rev Prat; 1977 Dec; 27(57):3999-4005. PubMed ID: 345400
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL; Malinin AI; Sane DC
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aspirin and dipyridamole inhibition of collagen-induced platelet aggregation and release in cynomolgus monkeys.
    Wang ZG; McCann RL; Hagen PO
    Chin Med J (Engl); 1984 Jan; 97(1):19-23. PubMed ID: 6428828
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
    Serebruany VL; Malinin AI; Sane DC; Jilma B; Takserman A; Atar D; Hennekens CH
    Eur J Pharmacol; 2004 Sep; 499(3):315-24. PubMed ID: 15381054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Use of aspirin in ischemic heart disease].
    Frishman W; Horwitz S
    Arch Inst Cardiol Mex; 1977; 47(2):129-31. PubMed ID: 901049
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aspirin in ischemic heart disease].
    Penkov N; Sirakova V
    Vutr Boles; 1990; 29(4):12-7. PubMed ID: 2281654
    [No Abstract]   [Full Text] [Related]  

  • 20. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.